MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SOROF, S.
Right arrow Articles by LUONGO, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SOROF, S.
Right arrow Articles by LUONGO, L.

Molecular Pharmacology, Vol 5, 625-639, Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics

Increased Selectivity of Interaction between Fluorenylamine Carcinogens and Liver Proteins during Hepatocarcinogenesis

SAM SOROF 1, EMILY M. YOUNG 1, REGINA Z. MCBRIDE 1, CAROL B. COFFEY 1, and LEONA LUONGO 1

1 The Institute for Cancer Research, Fox Chase, Philadelphia, Pennsylvania 19111

The continued ingestion of a fluorenylamine hepatocarcinogen by rats results in a marked change toward a highly selective interaction between the carcinogen and particular target liver proteins. Adult male rats were fed for 5 weeks a diet lacking (control) or containing the liver carcinogen N-2-fluorenylacetamide (2-acetylaminofluorene, FAA). They were then given single doses of N-2-fluorenylacetamide-9-14C intragastrically and killed 48 hr later. The soluble liver proteins were resolved extensively by column electrophoresis. Control liver profiles displayed a diffuse distribution of fluorenyl-14C-proteins. In contrast, the profiles from rats previously fed the carcinogen displayed a highly localized concentration of bound 14C-labeled carcinogen at one or two weakly basic classes of proteins (fast h2 and/or slow h1). These regions contained about one-third of all the soluble fluorenyl-14C-proteins of liver, and represented a 3-4-fold increase over that in control profiles. Each of the two conjugates displayed a degree of electrophoretic homogeneity resembling that of a single macromolecule. The relative proportion of the two species varied considerably. The more anionic one (slow h1) was labile.

The possibility that the specificity of protein binding in vivo resided in the activation of FAA by N-hydroxylation was examined by administration of the proximate carcinogen N-hydroxy-FAA-9-14C to rats likewise previously fed FAA. This premise was not supported by the finding of a similar h specificity of the distribution of radioactivity.

In contrast to the h specificity of the preneoplastic livers of FAA-fed rats, unperfused primary liver tumors induced by FAA contained mostly soluble fluorenyl-14C-proteins which were weakly acidic (A proteins) and had a mobility similar to that of serum albumin.

Submitted on May 12, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics